{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:16Z","timestamp":1792839676149,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900504"],"award-info":[{"award-number":["81900504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974071"],"award-info":[{"award-number":["81974071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270558"],"award-info":[{"award-number":["82270558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110576","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T22:10:54Z","timestamp":1687990254000},"page":"110576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The proportion of regulatory T cells in peripheral blood of patients with autoimmune hepatitis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3021-2472","authenticated-orcid":false,"given":"Zheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangshu","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7073-6174","authenticated-orcid":false,"given":"Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2023.110576_b0005","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41423-021-00768-8","article-title":"Autoimmmune hepatitis","volume":"19","author":"Terziroli Beretta-Piccoli","year":"2022","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.110576_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575572","article-title":"Regulatory T cells in autoimmune hepatitis: unveiling their roles in mouse models and patients","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jhep.2018.11.006","article-title":"Grand round: autoimmune hepatitis","volume":"70","author":"Trivedi","year":"2019","journal-title":"J. Hepatol."},{"issue":"24","key":"10.1016\/j.intimp.2023.110576_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413578","article-title":"Pathogenesis of autoimmune hepatitis-cellular and molecular mechanisms","volume":"22","author":"Sirbe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.110576_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: an updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells","volume":"6","author":"von Boehmer","year":"2005","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0035","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10620-021-06968-6","article-title":"Immune inhibitory properties and therapeutic prospects of transforming growth factor-beta and interleukin 10 in autoimmune hepatitis","volume":"67","author":"Czaja","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2023.110576_b0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0045","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0961203319828530","article-title":"Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis","volume":"28","author":"Zhu","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2023.110576_b0050","doi-asserted-by":"crossref","first-page":"1058738","DOI":"10.1155\/2019\/1058738","article-title":"The proportion of regulatory T cells in patients with ankylosing spondylitis: a meta-analysis","volume":"2019","author":"Lai","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"9","key":"10.1016\/j.intimp.2023.110576_b0055","doi-asserted-by":"crossref","first-page":"e0162306","DOI":"10.1371\/journal.pone.0162306","article-title":"The proportion of regulatory T cells in patients with rheumatoid arthritis: a meta-analysis","volume":"11","author":"Morita","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110576_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726128","article-title":"Glucose metabolism reprogramming of regulatory T cells in concanavalin A-induced hepatitis","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110576_b0065","doi-asserted-by":"crossref","first-page":"3753081","DOI":"10.1155\/2018\/3753081","article-title":"The imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis","volume":"2018","author":"Liang","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2023.110576_b0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","article-title":"T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile","volume":"41","author":"Longhi","year":"2013","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.intimp.2023.110576_b0075","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.110576_b0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clim.2018.11.003","article-title":"Treg\/Th17 imbalance is associated with poor autoimmune hepatitis prognosis","volume":"198","author":"Liu","year":"2019","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110576_b0085","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1038\/s41419-017-0010-y","article-title":"Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis","volume":"8","author":"John","year":"2017","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.110576_b0090","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110576_b0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110576_b0100","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1872-034X.2008.00349.x","article-title":"Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4(+)CD25(+) T cells in patients with autoimmune hepatitis","volume":"38","author":"Okumura","year":"2008","journal-title":"Hepatol. Res.: Off. J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.intimp.2023.110576_b0105","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.intimp.2023.110576_b0110","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110576_b0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver D. Diagnosis and treatment of autoimmune hepatitis","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.intimp.2023.110576_b0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.110576_b0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110576_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110576_b0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.110576_b0140","unstructured":"J. Hu, F. Zhang, L. Zhang, J. Ding, The increased ratio of peripheral blood Th17 cells\/regulatory T cells and its related factors in some patients with autoimmune hepatitis in Xinjiang Uyghur Nationality. Chin. J. Cell. Mol. Immunol. 32(9) (2016) 1248\u201350+54."},{"issue":"18","key":"10.1016\/j.intimp.2023.110576_b0145","first-page":"3447","article-title":"Role of CD4+CD25+ regulatory T cells on the pathogenesis of autoimmune hepatitis","volume":"10","author":"Zhou","year":"2010","journal-title":"Prog. Mod. Biomed."},{"key":"10.1016\/j.intimp.2023.110576_b0150","first-page":"1","article-title":"Study of CD4+CD25+high regulatory T cells in patients with autoimmune hepatitis","volume":"03","author":"Xu","year":"2008","journal-title":"Chin. J. Mod. Drug Appl."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0155","first-page":"337","article-title":"CD4+CD25+high regulatory T cells in patients with autoimmune hepatitis","volume":"21","author":"Li","year":"2007","journal-title":"Chin. J. Exp. Clin. Virol."},{"issue":"19","key":"10.1016\/j.intimp.2023.110576_b0160","first-page":"2872","article-title":"Detection and clinical significance of CD4+CD25+Foxp3+ regulatory T cells in patients with autoantibody-positive chronic hepatitis B","volume":"24","author":"Wu","year":"2013","journal-title":"Hainan Med. J."},{"issue":"9","key":"10.1016\/j.intimp.2023.110576_b0165","first-page":"1443","article-title":"Studies on the population of Th17 and Treg cells and the expression of the correlated cytokines in autoimmune liver disease patients","volume":"18","author":"Wang","year":"2014","journal-title":"Chin. J. Lab. Diag."},{"issue":"6","key":"10.1016\/j.intimp.2023.110576_b0170","first-page":"598","article-title":"HLA-DR mRNA levels, Th17 and CD4+CD25+Treg cell percentages in peripheral blood mononuclear cells in patients with liver failure","volume":"18","author":"Liu","year":"2015","journal-title":"J. Pract. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0175","first-page":"215","article-title":"The level of regulatory T lymphocytes in peripheral blood of patients with autoimmune hepatitis and primary biliary cholangitis overlap syndrome","volume":"33","author":"Zhang","year":"2019","journal-title":"J. China-Japan Friendship Hospital"},{"issue":"6","key":"10.1016\/j.intimp.2023.110576_b0180","first-page":"934","article-title":"Expression of autophagy gene in PBMCs and correlation between Th17\/CD4+CD25+CD127low Treg cells and liver function in autoimmune hepatitis","volume":"24","author":"Wang","year":"2020","journal-title":"Chin. J. Lab. Diag."},{"issue":"24","key":"10.1016\/j.intimp.2023.110576_b0185","first-page":"3728","article-title":"The relationship between regulatory T cells and related cytokines and liver function damage of autoimmune hepatitis patients","volume":"33","author":"Gao","year":"2011","journal-title":"Hebei Med. J."},{"issue":"5","key":"10.1016\/j.intimp.2023.110576_b0190","article-title":"Test result of peripheral blood CD4+CD25+ regulatory T cells of autoimmune hepatitis patients","volume":"24","author":"Chen","year":"2012","journal-title":"Shanghai J. Prev. Med."},{"key":"10.1016\/j.intimp.2023.110576_b0195","unstructured":"H. Zhang, Clinical Features of Autoimmune Hepatitis Patients with Poor Response to Treatment and In Vitro Study of UC-MSCs Therapy. Master's Dissertation, 2018, Tianjin Medical University."},{"key":"10.1016\/j.intimp.2023.110576_b0200","unstructured":"Ai G. The role and mechanism of CD4+CD25+FOXP3+ Treg cells and its effector molecule FGL2 in autoimmune hepatitis. Doctor's Dissertation. 2013;Huazhong University of Science & Technology."},{"issue":"35","key":"10.1016\/j.intimp.2023.110576_b0205","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.11569\/wcjd.v21.i35.4006","article-title":"Abnormal peripheral blood lymphocyte subsets in patients with autoimmune hepatitis","volume":"21","author":"Xiao","year":"2013","journal-title":"World Chinese Journal of Digestology."},{"issue":"2","key":"10.1016\/j.intimp.2023.110576_b0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hbpd.2018.02.004","article-title":"CD4(+)Foxp3(+)CD25(+\/-) Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: a clinical-pathological study","volume":"17","author":"Qu","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.intimp.2023.110576_b0215","unstructured":"D. Guo, The role of CD4+CD25+FOXP3+ regulatory T cells in autoimmune hepatitis. Master's Dissertation, Huazhong University of Science & Technology, 2016."},{"issue":"05","key":"10.1016\/j.intimp.2023.110576_b0220","article-title":"Expressions of miR-21 and miR-155 in peripheral blood of patients with autoimmune liver disease and their relationships with Th17 and Treg cell balance","volume":"29","author":"Zha","year":"2020","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110576_b0225","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0230","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110576_b0235","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.coi.2009.05.007","article-title":"Plasticity of CD4(+) FoxP3(+) T cells","volume":"21","author":"Zhou","year":"2009","journal-title":"Curr Opin Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110576_b0240","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/eji.200526189","article-title":"Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level","volume":"35","author":"Roncador","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110576_b0245","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110576_b0250","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.110576_b0255","doi-asserted-by":"crossref","first-page":"1053216","DOI":"10.3389\/fimmu.2022.1053216","article-title":"Standard immunosuppressive treatment reduces regulatory B cells in children with autoimmune liver disease","volume":"13","author":"Yuksel","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110576_b0260","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.intimp.2023.110576_b0265","first-page":"592","article-title":"Differentiation of regulatory T cells induced by vitamin D and its role in the pathogenesis of autoimmune hepatitis","volume":"34","author":"Tian","year":"2017","journal-title":"J. Xinxiang Med. Univ."},{"key":"10.1016\/j.intimp.2023.110576_b0270","doi-asserted-by":"crossref","unstructured":"I.P. Dos Santos, M.T. de Assuncao, R.M. Mauch, N.S. Sandy, M.T. Nolasco da Silva, M.A. Bellomo-Brandao et al., Patients with treated autoimmune hepatitis and persistent suppression of plasmacytoid dendritic cells: a different point of view, Int. J. Immunopathol. Pharmacol. 36 (2022) 20587384211068667.","DOI":"10.1177\/20587384211068667"},{"issue":"04","key":"10.1016\/j.intimp.2023.110576_b0275","first-page":"298","article-title":"The significance of hepatic regulatory T cells in patients with autoimmune hepatitis","volume":"16","author":"He","year":"2011","journal-title":"Chinese Hepatology."},{"issue":"7\u20138","key":"10.1016\/j.intimp.2023.110576_b0280","doi-asserted-by":"crossref","first-page":"e3023","DOI":"10.1002\/jgm.3023","article-title":"Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function","volume":"20","author":"Ai","year":"2018","journal-title":"J. Gene Med."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0285","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1386207322666190402160455","article-title":"Expression and significance of Th17 cells and related factors in patients with autoimmune hepatitis","volume":"22","author":"An","year":"2019","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0290","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","volume":"1","author":"Oo","year":"2019","journal-title":"JHEP Rep."},{"issue":"4","key":"10.1016\/j.intimp.2023.110576_b0295","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.110576_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102629","article-title":"Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis","volume":"119","author":"McEachern","year":"2021","journal-title":"J. Autoimmun."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:21:03Z","timestamp":1736432463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":60,"alternative-id":["S1567576923009025"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110576","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The proportion of regulatory T cells in peripheral blood of patients with autoimmune hepatitis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110576"}}